Skip to main content

Table 3 Cost-effectiveness analysis of routine plus catch-up vs routine 9vHPV female-only vaccination strategies

From: The impact and cost-effectiveness of 9-valent human papillomavirus vaccine in adolescent females in Hong Kong

 

Discounted total

Incremental

Costs/person (HKD)

QALYs/Person (y)

Costs/person (HKD)

QALYs/person (y)

Costs/QALYs (HKD/y)

Routine 9vHPV FOV

1855.97

27.25912

NA

NA

NA

Routine plus catch-up 9vHPV FOV

1879.45

27.25990

23.48

0.000785

29,911a

  1. 9vHPV 9-valent human papillomavirus, FOV female-only vaccination, HKD Hong Kong dollar, ICER incremental cost-effectiveness ratio, NA not applicable, QALY quality-adjusted life-year
  2. aIncremental costs, QALYs, and ICERS with respect to routine 9vHPV FOV
Back to article page

Cost Effectiveness and Resource Allocation

ISSN: 1478-7547

Contact us